FASCINATION ABOUT HEMGENIX

Range of suitable people: CDEC mentioned the uncertainty in the amount of individuals with moderately serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some people that are labeled as acquiring gentle or moderate disease may have a intense bleeding phenoty